NSE - Delayed Quote INR
DR AGARWALS HEALTH CARE L (AGARWALEYE.NS)
353.60
-11.30
(-3.10%)
At close: May 2 at 3:30:01 PM GMT+5:30
Breakdown
TTM
3/31/2024
3/31/2023
3/31/2022
Total Revenue
15,934,640
14,226,580
10,164,820
6,952,650
Cost of Revenue
8,861,520
7,884,520
5,591,720
3,861,500
Gross Profit
7,073,120
6,342,060
4,573,100
3,091,150
Operating Expense
4,539,280
4,014,790
3,037,580
2,130,910
Operating Income
2,533,840
2,327,270
1,535,520
960,240
Net Non Operating Interest Income Expense
-1,068,470
-958,340
-716,420
-457,600
Pretax Income
1,918,130
1,818,300
835,910
567,630
Tax Provision
575,570
560,050
-196,390
135,990
Net Income Common Stockholders
1,057,640
1,016,900
940,970
376,940
Diluted NI Available to Com Stockholders
1,057,640
1,016,900
940,970
376,940
Rent Expense Supplemental
131,350
142,510
141,260
95,460
Total Expenses
13,400,800
11,899,310
8,629,300
5,992,410
Net Income from Continuing & Discontinued Operation
1,057,640
1,016,900
940,970
376,940
Normalized Income
1,101,623.71
1,016,900
939,766
419,029.52
Interest Income
74,600
80,250
48,480
32,340
Interest Expense
1,054,230
958,340
719,730
453,990
Net Interest Income
-1,068,470
-958,340
-716,420
-457,600
EBIT
2,972,360
2,776,640
1,555,640
1,021,620
EBITDA
4,997,100
4,500,740
2,838,600
1,961,190
Reconciled Cost of Revenue
8,861,520
7,884,520
5,591,720
3,861,500
Reconciled Depreciation
2,004,300
1,703,660
1,282,960
939,570
Net Income from Continuing Operation Net Minority Interest
1,057,640
1,016,900
940,970
376,940
Total Unusual Items Excluding Goodwill
-62,840
201,600
1,720
-55,350
Total Unusual Items
-62,840
201,600
1,720
-55,350
Normalized EBITDA
5,059,940
4,500,740
2,836,880
2,016,540
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
-18,856.29
--
516
-13,260.48
3/31/2022 - 2/4/2025
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade